-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$IRS4 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$KCNH4 !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($CCNE2 !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$CARD9 !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS !$postmenopausal_only $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS !$estrogen_receptor_blocker_and_stops_production $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-201 and(or(and(or(0<($tumor_size_cm_preTrt_preSurgery) !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-200 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) or(!$VPS8 !$FOS $taxane $capecitabine) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-207 and(or(and(!$PYCARD $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL !$fluorouracil) !$IFIT1) or(not(0<($tumor_size_cm_preTrt_preSurgery)) $PSMD5)) 
-206 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL !$fluorouracil) !$IFIT1) or($PSMD5 $anti_estrogen)) 
-206 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL !$fluorouracil) !$IFIT1) or($PSMD5 !$trastuzumab)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $anti_HER2 $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 !$chemotherapyClass $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen) $oral) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen) $hormone_therapyClass) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1 $anastrozole) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL !$fluorouracil) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B !$intarvenous) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B !$oral) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B $letrozole) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and(!$PYCARD !$DUOX2) $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and(!$PYCARD !$estrogen_receptor_blocker_and_stops_production) $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($CLINT1 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and(!$C20orf43 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($DAO $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and(!$MYBPC2 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($NHLH2 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B $ING2) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B $MDM1) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B $CTNNA1) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B !$SLCO4A1) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B !$PFN2) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(and($GPM6B $oral) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) or($estrogen_receptor_blocker_and_stops_production $trastuzumab)) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) and($TNNI1 $postmenopausal_only)) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) and($postmenopausal_only !$epirubicin)) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($PSMD5 !$F2RL3) $PEBP1 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($PSMD5 $taxane) $PEBP1 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(!$DTX2 $PEBP1) $PSMD5 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($MYBPC2 $PEBP1) $PSMD5 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($MYBPC2 $anti_estrogen) $PSMD5 $PEBP1) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(!$NHLH2 $PEBP1) $PSMD5 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or(and($PEBP1 !$ARID4B) $PSMD5 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or(and($PEBP1 !$SLC6A8) $PSMD5 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or(and($PEBP1 !$epirubicin) $PSMD5 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or(and(!$FOS $anti_estrogen) $PSMD5 $PEBP1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($ICT1 $KEL) !$IFIT1) or(and($anti_estrogen !$cyclophosphamide) $PSMD5 $PEBP1)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) and(not(0<($nuclear_grade_preTrt)) $postmenopausal_only)) or(and($ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-205 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(not(0<($race)) $PEBP1) $PSMD5 $anti_estrogen) or(and($ICT1 $KEL) !$IFIT1)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen $anastrozole)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1 !$F2RL3) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B $other) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(and(!$OR12D3 !$PYCARD) $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(and($TSPAN32 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(and($PSMD5 $GPM6B) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(and($PPEF1 !$ITPKC) $ICT1) $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(and($GPM6B $ING2) !$PYCARD) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) or(!$chemotherapyClass $trastuzumab)) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) or($KEL !$MAP3K7)) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($PSMD5 $hormone_therapyClass) $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($DLX6 $anti_estrogen) $PSMD5 $PEBP1)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($PEBP1 $ST6GALNAC4) $PSMD5 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($PEBP1 $CBX4) $PSMD5 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($PEBP1 !$SLC6A8) $PSMD5 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($PEBP1 !$epirubicin) $PSMD5 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(and($anti_estrogen !$epirubicin) $PSMD5 $PEBP1)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($PPEF1 $ICT1) $KEL) !$IFIT1) or(0<($nuclear_grade_preTrt) $PSMD5 $PEBP1 $anti_estrogen)) 
-204 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and($PSMD5 !$F2RL3) and(!$FOS $anti_estrogen) $PEBP1) or(and($ICT1 $KEL) !$IFIT1)) 
-203 and(or(and(or(and($capecitabine !$fluorouracil) !$VPS8 !$FOS !$C9orf38) $ICT1 $KEL) !$IFIT1) or(and(!$PYCARD $trastuzumab) $postmenopausal_only) or($PSMD5 $anti_estrogen)) 
-203 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$CARD9 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-203 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$FOS $taxane $capecitabine $fluorouracil) $ICT1 $KEL) !$IFIT1) or($PSMD5 $anti_estrogen)) 
-203 and(or(and(or(!$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(!$PYCARD $trastuzumab) $postmenopausal_only) or(and($anti_estrogen !$cyclophosphamide) $PSMD5 $PEBP1)) 
-203 and(or(and(or(and($POLR2C $capecitabine) !$FOS $taxane) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $anti_estrogen)) 
-203 and(or(and(or(and($capecitabine !$fluorouracil) !$VPS8 !$FOS) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $anti_estrogen)) 
-203 and(or(and(or(and($capecitabine !$fluorouracil) !$FOS $taxane) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $anti_estrogen)) 
-203 and(or(and(or(0<($tumor_size_cm_preTrt_preSurgery) !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(and($capecitabine !$other) !$VPS8 !$FOS $taxane) $ICT1 $KEL) !$IFIT1) or(and(!$PYCARD $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$OR12D3 !$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or($DDN !$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$GABRQ !$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $MYBPC2 $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $hormone_therapyClass $trastuzumab) $postmenopausal_only) or(and(or(!$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) !$intarvenous $postmenopausal_only) or(and(or(!$IRS4 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$C20orf43 !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($DAO !$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or($CCNE2 !$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$CARD9 !$IRS4 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$CARD9 !$FOS $taxane $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 $NHLH2 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS !$RAD50 $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $taxane $capecitabine $fluorouracil) $ICT1 $KEL) !$IFIT1) or($PSMD5 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$MYBPC2 !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 !$intarvenous $anti_estrogen)) 
-202 and(or(and(or(!$PYCARD $GPM6B) $trastuzumab) $postmenopausal_only) or(and(or(!$VPS8 !$FOS $capecitabine) $ICT1 $KEL) !$IFIT1) or($PSMD5 $PEBP1 $anti_estrogen) !$other) 
